More MS news articles for April 2004

Cladribine - will it be the first oral therapy for MS?

http://www.bostoncure.org:8080/article.pl?sid=04/04/01/1240247&mode=nested

April 1, 2004
Art Mellor
Boston Cure Project

Serono and IVAX report:
...positive results from two clinical trials with a new proprietary oral formulation of cladribine, a potential new treatment for multiple sclerosis (MS). The study results showed that the formulation of oral cladribine which has been developed by Serono and IVAX has met the targets for an orally administered product, with blood levels of cladribine in the expected therapeutic range. Efficacy studies of oral cladribine in MS patients are planned to start late 2004.